Zdrowie i gospodarka · 23/10/2013
FDA Corrects Public Meeting on Patient-Focused Drug Development for Fibromyalgia
The FDA is correcting a document that announced a public meeting on patient-focused drug development for fibromyalgia, which incorrectly stated the submission deadline for public comments, originally set for September 23, 2013.